REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

E.S.E. Clinica Guane - Floridablanca (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: E.S.E. Clinica Guane - Floridablanca Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

E.S.E. Clinica Guane - Floridablanca is an enterprise based in Colombia. Its main office is in Floridablanca. The enterprise operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on December 30, 2014. In Q3C2024, the company reported a net sales revenue drop of 2.41%. Its total assets grew by 23.57% over the same period. The net profit margin of E.S.E. Clinica Guane - Floridablanca decreased by 22.56% in 2024.

Headquarters
Calle 4 # 7-01
Floridablanca; Santander; Postal Code: 681001

Contact Details: Purchase the E.S.E. Clinica Guane - Floridablanca report to view the information.

Website: http://clinicaguane.gov.co

Basic Information
Outstanding Shares:
Purchase the E.S.E. Clinica Guane - Floridablanca report to view the information.
Incorporation Date:
December 30, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Head of Internal Control
Company Performance
Financial values in the chart are available after E.S.E. Clinica Guane - Floridablanca report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-2.41%▼
Total operating revenue
-2.29%▼
Operating profit (EBIT)
-97.76%▼
EBITDA
-86.77%▼
Net Profit (Loss) for the Period
-97.8%▼
Total assets
23.57%▲
Total equity
-34.5%▼
Operating Profit Margin (ROS)
-23.18%▼
Net Profit Margin
-22.56%▼
Return on Equity (ROE)
-21.17%▼
Quick Ratio
-22.14%▼
Cash Ratio
-3.91%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo